410 related articles for article (PubMed ID: 21712239)
1. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates.
Solomon K; Fanning S; McDermott S; Murray S; Scott L; Martin A; Skally M; Burns K; Kuijper E; Fitzpatrick F; Fenelon L; Kyne L
J Antimicrob Chemother; 2011 Sep; 66(9):1976-82. PubMed ID: 21712239
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.
Spigaglia P; Barbanti F; Dionisi AM; Mastrantonio P
J Clin Microbiol; 2010 Aug; 48(8):2892-6. PubMed ID: 20554809
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance.
Pituch H; Brazier JS; Obuch-Woszczatyński P; Wultańska D; Meisel-Mikołajczyk F; Łuczak M
J Med Microbiol; 2006 Feb; 55(Pt 2):207-213. PubMed ID: 16434714
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of Clostridium difficile in Scotland.
Wiuff C; Brown DJ; Mather H; Banks AL; Eastaway A; Coia JE
J Infect; 2011 Apr; 62(4):271-9. PubMed ID: 21300104
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
[TBL] [Abstract][Full Text] [Related]
6. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.
Drudy D; Quinn T; O'Mahony R; Kyne L; O'Gaora P; Fanning S
J Antimicrob Chemother; 2006 Dec; 58(6):1264-7. PubMed ID: 17018563
[TBL] [Abstract][Full Text] [Related]
7. Analysis of macrolide-lincosamide-streptogramin B (MLS(B)) resistance determinant in strains of Clostridium difficile.
Spigaglia P; Mastrantonio P
Microb Drug Resist; 2002; 8(1):45-53. PubMed ID: 12002649
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.
Ackermann G; Degner A; Cohen SH; Silva J; Rodloff AC
J Antimicrob Chemother; 2003 Mar; 51(3):599-603. PubMed ID: 12615860
[TBL] [Abstract][Full Text] [Related]
9. Transfer of Clostridium difficile Genetic Elements Conferring Resistance to Macrolide-Lincosamide-Streptogramin B (MLSB) Antibiotics.
Barbanti F; Wasels F; Spigaglia P
Methods Mol Biol; 2016; 1476():187-98. PubMed ID: 27507342
[TBL] [Abstract][Full Text] [Related]
10. Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.
Carman RJ; Genheimer CW; Rafii F; Park M; Hiltonsmith MF; Lyerly DM
Anaerobe; 2009 Dec; 15(6):244-8. PubMed ID: 19818865
[TBL] [Abstract][Full Text] [Related]
11. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
Poilane I; Fantinato C; Cruaud P; Collignon A
Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
[TBL] [Abstract][Full Text] [Related]
13. Inter- and intraspecies transfer of a Clostridium difficile conjugative transposon conferring resistance to MLSB.
Wasels F; Monot M; Spigaglia P; Barbanti F; Ma L; Bouchier C; Dupuy B; Mastrantonio P
Microb Drug Resist; 2014 Dec; 20(6):555-60. PubMed ID: 25055190
[TBL] [Abstract][Full Text] [Related]
14. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.
Kim J; Kang JO; Pai H; Choi TY
Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765
[TBL] [Abstract][Full Text] [Related]
15. Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106.
Ratnayake L; McEwen J; Henderson N; Nathwani D; Phillips G; Brown D; Coia J
J Hosp Infect; 2011 Nov; 79(3):242-7. PubMed ID: 21864938
[TBL] [Abstract][Full Text] [Related]
16. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm.
Huang H; Fang H; Weintraub A; Nord CE
Clin Microbiol Infect; 2009 Dec; 15(12):1170-3. PubMed ID: 19624517
[TBL] [Abstract][Full Text] [Related]
17. Macrolide-lincosamide-streptogramin B resistance phenotypes in clinical staphylococcal isolates.
Cetin ES; Gunes H; Kaya S; Aridogan BC; Demirci M
Int J Antimicrob Agents; 2008 Apr; 31(4):364-8. PubMed ID: 18206352
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.
Walkty A; Boyd DA; Gravel D; Hutchinson J; McGeer A; Moore D; Simor A; Suh K; Taylor G; Miller M; Mulvey MR;
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):419-24. PubMed ID: 20226332
[TBL] [Abstract][Full Text] [Related]
19. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.
Johnson S; Samore MH; Farrow KA; Killgore GE; Tenover FC; Lyras D; Rood JI; DeGirolami P; Baltch AL; Rafferty ME; Pear SM; Gerding DN
N Engl J Med; 1999 Nov; 341(22):1645-51. PubMed ID: 10572152
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
Lachowicz D; Pituch H; Obuch-Woszczatyński P
Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
